UPDATE 1-U.S. FDA panel backs Medtronic device for epilepsy

* Panel votes 7-5 to recommend approval with conditions

* FDA will consider panel's advice

GAITHERSBURG, Md., March 12 (Reuters) - An implanted
Medtronic Inc (MDT.N: Quote, Profile, Research) brain device should be approved for
treating epilepsy, U.S. government advisers said on Friday.

A Food and Drug Administration advisory panel voted 7-5 to
recommend approval of the Deep Brain Stimulation (DBS) therapy
for epilepsy, a brain disorder that causes seizures. The device
already is sold for treating Parkinson's disease and other
disorders.

The panel said the FDA should require warnings about
suicidal behavior and depression and follow-up studies of up to
five years after approval.

The FDA will consider the panel recommendation. The agency
usually approves products that win support from advisory
committees.
(Reporting by Lisa Richwine; editing by Andre Grenon)